WCPO: Inflation could cause consumers to change spending habits
UC economist says 40-year inflation high ‘affects everybody’
According to the U.S. Department of Labor, inflation is at a 40-year high. Consumers are being affected across the board with their expenditures.
“It’s more bad news for the average American consumer. Inflation affects everybody,” Michael Jones, PhD, associate professor-educator of economics at the University of Cincinnati Carl H. Lindner College of Business, told WCPO.
Jones said businesses should expect consumers to change their spending habits.
“There are some expenditures that they can’t go without,” Jones said. “But the things like entertainment purchases, or today is the Reds’ Opening Day, and so consumers don’t have to go to the Reds game. They can spend their money elsewhere.”
Jones said it’s unclear how long the record high in inflation will last, and that there are multiple issues contributing to these economic tough times, notably supply chain issues, the government stimulus bill and the war in Ukraine.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC students use 1819 Makerspace to build award-winning scoliosis...
December 18, 2024
Three University of Cincinnati students used the 1819 Ground Floor Makerspace to invent and test a groundbreaking treatment for pediatric scoliosis.
Winter can bring increased risk of stroke
December 18, 2024
The University of Cincinnati's Lauren Menzies joined Fox 19's morning show to discuss risk factors for stroke in the winter and stroke signs to look for.
High-dose vitamin C shows promise in pancreatic cancer treatment
December 17, 2024
The University of Cincinnati Cancer Center's Olugbenga Olowokure was featured in a Local 12 story discussing new research from the University of Iowa that suggests that high doses of vitamin C, when combined with standard chemotherapy, may significantly extend the life expectancy of patients with advanced pancreatic cancer.